Clinical Trial Update: Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis [NA]

View source ↗

Summary

A Cairo University-led clinical trial is evaluating epigallocatechin gallate (EGCG) as a flushing agent during full pulpotomy for irreversible pulpitis in matur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irreversible Pulpitis

Drugs mentioned

• Epigallocatechin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: Cairo University | Conditions: Irreversible Pulpitis | NA | Status: ACTIVE_NOT_RECRUITING